{
    "nct_id": "NCT06578637",
    "official_title": "Investigation of Î²-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis",
    "inclusion_criteria": "* Have a diagnosis of FAP with genetic testing demonstrating a pathogenic or likely pathogenic germline variant in APC, must have a clinical FAP phenotype with at least one member of the family who has a pathogenic or likely pathogenic germline variant in APC, or must have a clinical diagnosis of FAP as agreed by two gastrointestinal cancer genetics experts\n* Must have an extensive colonic resection with either a subtotal colectomy with ileorectal anastomosis (STC-IRA) or total proctocolectomy with ileal pouch anal anastomosis (TPC-IPAA)\n* Can provide informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Subject is pregnant, a prisoner, or is under 18 years of age\n* Prior total proctocolectomy with end ileostomy\n* History of inflammatory bowel disease\n* History of diabetes mellitus and are currently on medical diabetes therapy\n* History of chronic kidney disease with an eGFR &lt; 60 mL/min/1.73m2\n* Cancer diagnosis where the subject is receiving active therapy\n* Use of either a ketogenic diet or intermittent fasting (defined as a fasting period of 16 hours or more per day that is not associated with a medical procedure) during the 4 weeks prior to enrollment\n\nPart B\n\nInclusion Criteria:\n\n* Have a diagnosis of FAP with genetic testing demonstrating a pathogenic or likely pathogenic germline variant in APC, must have a clinical FAP phenotype with at least one member of the family who has a pathogenic or likely pathogenic germline variant in APC, or must have a clinical diagnosis of FAP as agreed by two gastrointestinal cancer genetics experts.\n* Scheduled for a colonoscopy or sigmoidoscopy as part of the patient's standard care\n* Able to have a concurrent upper endoscopy performed with the standard of care colonoscopy/sigmoidoscopy\n* Have at least two colorectal polyps (which can be present anywhere in the colon including the rectal cuff, or in the J-pouch [if applicable])\n* Can provide informed consent\n\nExclusion Criteria:\n\n* Subject is pregnant, a prisoner, or is under 18 years of age\n* Patient is not able to undergo colonoscopy/sigmoidoscopy or upper endoscopy\n* Prior total proctocolectomy with end ileostomy\n* History of inflammatory bowel disease\n* History of diabetes mellitus and are currently on medical diabetes therapy\n* History of chronic kidney disease with an eGFR &lt; 60 mL/min/1.73m2\n* Cancer diagnosis where the subject is receiving active therapy\n* Use of either a ketogenic diet or intermittent fasting (defined as a fasting period of 16 hours or more per day that is not associated with a medical procedure) during the 4 weeks prior to enrollment\n* Regular use of any FAP-related chemopreventive agent in the 6 weeks prior to enrollment including aspirin (&gt; 81mg daily), NSAIDs, BHB supplementation, or any other medication deemed a chemopreventive agent by the study investigators\n* Any colonic or small intestinal polyp observed endoscopically that is &gt; 1 cm in size and is not removed (excluding ampullary adenomas)",
    "miscellaneous_criteria": "Part A"
}